Archive | Healthcare Huddle

Healthcare Huddle
Archive
Page 3

Archive

The Unbundling: Is Blue Shield’s Big Move a PBM Game-Changer?

Jared Dashevsky, MD

Jared Dashevsky, MD

The Rise of Humira Biosimilars and the Adoption Challenge

Jared Dashevsky, MD

Jared Dashevsky, MD

Cost Plus Drugs: Key Updates from H1 ‘23

Jared Dashevsky, MD

Jared Dashevsky, MD

Medicare vs. Pharma: The Legal Fallout of the Inflation Reduction Act

Jared Dashevsky, MD

Jared Dashevsky, MD

Prescription Predicament: How Three New Models are Tackling Drug Prices

Huddle+ | Huddle #Trends

Jared Dashevsky, MD

Jared Dashevsky, MD

Looking Back, Looking Ahead: Mark Cuban’s Cost Plus Drugs Company

Jared Dashevsky, MD

Jared Dashevsky, MD

The End of the Billion-Dollar Drug

Jared Dashevsky, MD

Jared Dashevsky, MD

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

Jared Dashevsky, MD

Jared Dashevsky, MD

Why Walgreens Launched a Clinical Trials Vertical

Jared Dashevsky, MD

Jared Dashevsky, MD

Healthcare Supply Chain Gone Haywire

Jared Dashevsky, MD

Jared Dashevsky, MD

The Netflix of Antibiotics

Jared Dashevsky, MD

Jared Dashevsky, MD

Mark Cuban’s New Pharmacy

Jared Dashevsky, MD

Jared Dashevsky, MD